Cinfa Biotech’s team is made up of about 25 renowned biosimilar experts who have a proven track record in developing and launching biosimilars and biopharmaceuticals in different indications and international markets. With a thorough understanding of protein-based therapeutics and disease biology, we conduct efficient biosimilar development programs. Our team benefits from the support and experience of the entire Cinfa Group. We have the freedom to pioneer and develop the biosimilar business as part of the strategic framework of the Group.